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Abstract: 
Melanosomes are lysosome-related organelles that produce and transport the pigment 
melanin within melanocytes. Mutations in proteins required for melanosome transport 
and formation lead to a range of pigmentation defects, manifested at the cellular level as 
perinuclear clustering of melanosomes, or reduced sorting of melanosomal cargo such as 
tyrosinase-related protein 1 (TYRP1). A pilot screen was carried out to investigate 
whether a combination of cellular imaging and RNA interference could be used to 
identify new proteins involved in pigmentation pathways. In this study, eleven genes 
known to play a role in melanosome transport/formation or other pigmentation properties 
were knocked down in mouse melanocytes with shRNAmir constructs. The investigated 
genes were TYRP1, pallidin, cappuccino, dysbindin, HPS5, LYST, Myosin Va, 
melanophilin, RhoA, UBPY and mahogunin. In a blinded confocal imaging experiment, 
the only reproducible change observed in cells in which these targets were knocked down 
was a decrease in TYRP1 levels upon transfection with knockdown constructs against 
TYRP1 itself, or one of three constructs targeting HPS5 (Hermansky-Pudlak Syndrome 
5). Upon analysis with high-content imaging software, only the knockdown construct 
against TYRP1 itself was detected. RT-PCR analysis showed that many of the shRNAmir 
constructs did not reduce mRNA and proteins levels enough to detect effects on 
melanosome properties. This was further examined for melanophilin, a protein necessary 
for melanosome transport. Altogether, the data show that this system is currently not 
sensitive enough for use in a screen for unknown regulators of melanosome transport and 
formation. The main obstacle appears to be incomplete reduction of target protein levels. 
Our observation that a ~50% reduction in mRNA level is not sufficient to elicit an effect 
is supported by the fact that heterozygous carriers of melanosomal transport disorders 
(Griscelli Syndrome, Hermansky-Pudlak Syndrome) do not display diseases phenotypes. 
A further reduction in protein levels, for example by viral integration of shRNA, may be 
required. 
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Introduction 
Melanosomes are specialized organelles in melanocytes, responsible for the synthesis and 
distribution of the pigment melanin 
1
. The mechanisms and proteins involved in 
formation and movement of melanosomes are similar to those of lysosome-related 
organelles in other cell types, such as synaptic vesicles in neurons, platelet dense granules 
in platelets, and lytic vesicles in T-cells 
2-4
. In diseases such as Hermansky-Pudlak 
Syndrome, Chediak-Higashi Syndrome, or Griscelli Syndrome, hypopigmentation caused 
by a defect in either formation of movement of melanosomes is accompanied by defects 
in other lysosome-related organelles, causing, for example, bleeding disorders, 
immunological abnormalities, or neurological symptoms 
5-11
. This makes melanosomes 
an interesting model for the study of organelle formation and transport in general. 
The ultimate aim of the work described here was the development of a high-content 
analysis RNA interference (RNAi) screen to identify proteins that affect melanosome 
formation or transport. A high-content analysis system to detect changes in melanosome 
formation or movement was previously set up on a Cellomics HCS KineticScan Reader 
(Cellomics KSR) using TYRP1 as a melanosomal label (Appendix 1). To optimize this 
system for the identification of unknown proteins affecting melanosome properties, a set 
of reliable controls needed to be found first. This paper describes the testing of small 
hairpin RNA (shRNA) knockdown constructs that may serve as a positive control for a 
high-content RNAi analysis of melanosomes using Cellomics KSR. Based on a search of 
the literature for genes involved in various aspects of pigmentation, eleven proteins were 
selected for knockdown: cappuccino, pallidin, dysbindin, Hermansky Pudlak Syndrom 5 
(HPS5), Myosin Va, melanophilin, lysosomal trafficking regulator (LYST), RhoA, 
UBPY (or ubiquitin specific peptidase 8 (USP8)), mahogunin, and tyrosinase-related 
protein 1 (TYRP1). 
Cappuccino, pallidin, and dysbindin were originally identified as proteins that cause a 
severe pigmentation defect in mice when mutated
12, 13
. These three proteins are 
components of the biogenesis of lysosome-related organelles complex 1 (BLOC-1), 
required for the proper sorting of cargo (such as TYRP1) from early endosomes to 
lysosome-related organelles 
14
. In humans, mutations in dysbindin are associated with 
Hermansky-Pudlak Syndrome type 7 and with an increased susceptibility to 
schizophrenia 
15, 16
. The latter is related to the formation of synaptic vesicles, highlighting 
the conserved pathways between melanosomes and other lysosome-related organelles. 
HPS5, a protein which, when mutated, leads to Hermansky-Pudlak Syndrome type 5, is a 
component of the protein complex BLOC-2, which acts downstream of BLOC-1 and is 
also involved in the sorting of proteins to lysosome-related organelles 
17, 18
. Myosin Va 
and melanophilin play a role in melanosome transport and are mutated in Griscelli 
Syndrome 
5, 7, 19-22
. LYST is mutated in Chediak-Higashi syndrome, where it produces 
giant lysosomes and melanosomes 
10, 23, 24
. Chemical inhibition of RhoA in mouse 
melanoma B16 cells increases dendrite extension, suggesting that its knockdown might 
have the same effect 
25
. UBPY is a deubiquitinating enzyme required for endosomal 
sorting 
26
. Mahogunin is an E3 ubiquitin ligase involved in regulating the melanocortin-1 
receptor-mediated balance between the brown/black pigment eumelanin and the 
yellow/red pigment pheomelanin 
27-29
. Finally, TYRP1 is involved in melanin synthesis, 
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and its sorting to melanosomes is regulated in part by pallidin, cappuccino, dysbindin, 
and HPS5 
14, 17, 30
. TYRP1 is also the label used in these experiments to detect 
melanosomes, and its knockdown is therefore expected to directly affect output. The 
known functions and predicted effects of knockdown of all proteins mentioned above are 
summarized in Table 1.  
In this study, the effect of knockdown of all target proteins was investigated in a blinded 
experiment using confocal microscopy. Knockdown of TYRP1 and HPS5 both showed a 
reproducible decrease in TYRP1 levels, but only knockdown of TYRP1 itself was 
detected using the Cellomics KSR. Limited knockdown and residual protein expression 
appear to be the major cause for the lack of effect of any of the other selected targets.  
 
Methods 
Cell Culture and Constructs 
Melan-a cells were obtained from the Wellcome Trust Functional Genomics Cell Bank 
and cultured at 37°C and 10% CO2 in RPMI-1640 with L-glutamine (Invitrogen, cat. 
11875) supplemented with 10% FBS, 100U/ml penicillin, 100 μg/ml streptomycin, 7.5 
μg/ml phenol red, 0.1 mM 2-mercaptoethanol, 2.7 mM HCl, and 200 nM PMA (added 
prior to use). 
Mouse genomic pGIPZ- shRNAmir vectors from the Hannon-Elledge library were 
purchased from Open Biosystems. These vectors express TurboGFP and transcribe an 
shRNAmir hairpin, both using a CMV promotor 
31
. pGIPZ constructs used are listed in 
Table 4-2. 
Cells for confocal analysis were transfected using Lipofectamine 2000 (Invitrogen) 
according to the manufacturer’s protocol, using 1μg DNA and 3 μl lipofectamine 2000 
per well in a 4-well chamber slide, seeded with 100,000 cells the previous day. Cells for 
Cellomics analysis were transfected as follows: Melan-a cells were transfected using 
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s protocol, using 0.25 μg 
DNA per well and 0.6 μl lipofectamine 2000 per well in a 96-well plate. 
Immunostaining 
For confocal analysis, cells were grown in 4-well polystyrene vessel glass slides (BD 
Falcon). At 48 or 72 hours after transfection with pGIPZ vectors, cells were fixed and 
stained for immunofluorescence. All steps were carried out at room temperature and 
without shaking to avoid cells detaching from the slide, and in the dark to avoid 
photobleaching. Samples were first stained for 5 minutes with Alexa-647 labeled 
Concanavalin A (Molecular Probes) to label the plasma membrane. The cells were then 
washed in PBS and fixed in 4% paraformaldehyde (PFA) in PBS for 20 minutes and 
permeabilized with a buffer of 0.1% Triton-X 100 and 1% BSA in PBS. Cells were 
blocked for 1 hour in 5% donkey serum (Jackson ImmunoResearch Laboratories). 
Samples were incubated for 1 hour with a mouse monoclonal antibody against TYRP1 
(AbCam) at 1:1000 dilution and a rabbit polyclonal antibody against TurboGFP 
(Evrogen) at 1:10,000 dilution in 1%BSA in PBS. After this, cells were washed three 
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times with 1% BSA in PBS, and incubated 45 minutes with Cy3-labeled donkey-anti-
mouse F(ab')2 (Jackson ImmunoResearch Laboratories) at 1:1000 and FITC-labeled 
donkey-anti-rabbit (Jackson ImmunoResearch Laboratories) secondary antibody in 1% 
BSA in PBS. After washing with PBS, slides were mounted using DAKO® Fluorescent 
mounting medium.  
To detect melanophilin knockdown by immunofluoresccnce, the same protocol was used, 
but with a goat polyclonal antibody against melanophilin (AbCam, 1:1000 dilution) 
instead of TYRP1 antibody, and secondary antibody 1:1000 donkey-anti-goat Cy3 
(Jackson ImmunoResearch Laboratories) instead of donkey-anti-mouse F(ab')2  
For Cellomics KSR analysis, cells were grown in 96-well plates (Corning), transfected as 
described, and fixed at the indicated times in 4% PFA in PBS. After fixation, 
permeabilization and immunostaining were carried out as described above until the final 
PBS wash step. Then cells were incubated for 5 minutes with DAPI nucleic acid stain 
(Molecular Probes), washed again, and kept in PBS (100 μl per well). 
Confocal Analysis 
Confocal analysis was carried out on a Zeiss Axiovert 200 inverted fluorescence 
microscope with 63X 1.2 water immersion C-Apochromat objective and analyzed with 
LSM510 software. To quantify levels of TYRP1 per cell, Volocity software was used to 
measure the total intensity of the Cy3 signal in all GFP-expressing cells, as well as the 
total intensity of the Cy3 signal in a similar number of cells that did not express GFP in 
the same fields, to account for variations in signal intensity between samples. Results 
were analyzed and presented using GraphPad, where error bars show the Standard Error 
of the Mean (S.E.M.) and unpaired T-test analysis was used to determine statistical 
significance between transfected and untransfected cells. The same protocol was 
followed to quantify melanophilin knockdown by immunofluorescence. 
Cellomics KSR analysis 
Plates were scanned on a Cellomics KineticScan® HCS Reader with 10x Plan-Neofluar 
objective. Images were acquired in 20 fields per well and in the following channels: 
DAPI was detected in XF93 Hoechst (0.040 second exposure), Cy3 in XF93 TRITC 
(0.500 second exposure) and FITC-labeled TurboGFP in the XF93 FITC channel (0.500 
second exposure). Each well was measured once (kinetic scan set to “single time point”). 
To determine TYRP1 levels, the SpotDetector BioApplication was used with the settings 
as shown in Appendix 1. Two protocol settings were used to measure spots: one 
measured transfected cells (SpotAvgIntenCh3 min = 25) and the other measured 
untransfected cells (SpotAvgIntenCh3 max = 24.999). 
RNA isolation and First Strand Synthesis 
To analyse mRNA levels after knockdown, cells were transfected with pGIPZ constructs 
and GFP-expressing cells were collected on a BD Aria-RITT sorter by fluorescence-
activated cell sorting (FACS) after 72 hours. Collected cells were immediately lysed in 
800 μl TRIZOL Reagent (Invitrogen) according to the manufacturer’s protocol. After 
phase separation with chloroform, 0.5 μl glycogen was added as a carrier to the aqueous 
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
do
i:1
0.
10
38
/n
pr
e.
20
09
.3
41
9.
1 
: P
os
te
d 
10
 J
ul
 2
00
9
phase. Final RNA pellet was taken up in 12 μl DEPC-treated water. After determining 
RNA concentration in the sample, 8 μl was converted to cDNA using the SuperScript III 
First-Strand Synthesis System for RT-PCR (real-time PCR) (Invitrogen) according to the 
manufacturer’s protocol. 
RT-PCR analysis 
After first-strand synthesis, cDNA levels of genes of interest were determined using 
quantitative PCR with Platinum SYBR Green qPCR SuperMix-UDG (Invitrogen), using 
12.5 μl SYBR Green, 1 ml each of forward and reverse primer (10 μM), 8.5 μl H2O and 
2 μl cDNA template. Primers are listed in table 4.3. All primers were designed to cross 
intron-exon boundaries, except primers for Cappuccino, which only has one exon. (For 
Cappuccino, RNA samples were treated with DNase to ensure removal of genomic 
DNA.) Samples were run for forty cycles (30 seconds 95ºC, 30 seconds 54 or 55ºC 
(depending on primers), 30 seconds 72ºC) on a Bio-Rad Chromo 4 Real-Time PCR 
detector and analyzed with Opticon Monitor and Genex (Bio-Rad) software. Expression 
levels were normalized to levels in cells transfected with the non-silencing control. 
Results 
Blinded confocal experiment to test pilot set of shRNA constructs 
In order to find a suitable control for high content analysis of proteins involved in 
melanosome formation or sorting, a blinded confocal analysis was carried out to find 
proteins for which knockdown results in a clearly detectable change in TYRP1 staining 
levels or location. 
Twenty-three pGIPZ constructs, against eleven target genes, were used to transfect 
melan-a cells in a blinded experiment, for which samples were relabeled and reordered. 
Cells were grown in four-well chamber slides. On every slide one well was transfected 
with a non-silencing control and three wells were transfected with blinded knockdown 
vectors. After fixing and staining, twenty confocal images were taken of every well. 
During this process two things were immediately obvious: First, there was a lot of 
variation in phenotype even among untransfected cells or non-silencing controls, and 
second, many transfected cells did not look any different from untransfected cells. The 
only obvious phenotype seen in some samples was a reduction in TYRP1 levels as 
visualized by a Cy3-tagged antibody. Figure 1 shows this reduction at 72 hour 
knockdown for two samples, which, after unblinding, were identified as samples in which 
either TYRP1 (top) or HPS5 (bottom) was knocked down.  
To quantify this observation, TYRP1 levels in transfected cells (identified by TurboGFP 
expression) were compared to TYRP1 levels in untransfected cells in the same well. 
TYRP1 levels per cell were measured using Volocity software and analyzed in 
GraphPad, where T-test analysis was used to determine whether the difference in TYRP1 
levels between transfected and untransfected cells was statistically significant. The P-
values obtained from this analysis are shown in Table 4, and graphs are shown in Figure 
2 (48 hour knockdown) and Figure 3 (72 hour knockdown). 
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At 72 hour knockdown, more samples show a higher statistically significant difference in 
TYRP1 levels between transfected and untransfected cells than at 48 hour knockdown. 
However, a statistically significant difference between transfected and untransfected cells 
does not necessarily correlate with a biologically significant difference. This is clear from 
the data collected from non-silencing controls: After both 48 hour and 72 hour 
transfections, two out of eight non-silencing controls show a statistically significant 
(P<0.05) reduction in TYRP1 levels in transfected cells compared to untransfected cells 
in the same wells. This suggests that there is a strong possibility that about a quarter of all 
“hits” for which P<0.05 are a false positive. To indicate this, the samples are ranked by 
reproducibility and P value in Table 4. Samples where a significant change in TYRP1 
levels was observed at both 48 and 72 hour knockdown are at the top, followed by 
samples that were only significant at 72 hour knockdown with P<0.01 or P<0.001. Under 
the horizontal line are all samples that only showed up as statistically significant for one 
time point with P<0.05 – in other words, all the samples that were no more significant 
than 25% of the negative controls. 
To investigate reproducibility, six of the top hits were analyzed again using confocal 
microscopy on cells fixed 72 hours after transfection. In this experiment, only two 
samples showed the same effect as before: knockdown of TYRP1 with construct 
v2LMM_12467 and knockdown of HPS5 with construct v2LMM_224489 (Table 4). 
Cellomics KSR High-Content Analysis of selected shRNA constructs 
Next, we investigated whether Cellomics KSR analysis would be able to pick up the 
same samples that show a reproducible reduction in TYRP1 on confocal analysis. The 
Cellomics KSR is a high-content imaging platform, which calculates several output 
values using specific image analysis algorithms called BioApplications, for which 
parameters can be adjusted by the user. Detection settings for melanosomes were 
previously optimized using this system with the Spot Detector BioApplication. 
Parameters for optimal detection of melanosomes are listed in Appendix 1.  
The Spot Detector BioApplication defines spots as localized regions of increased TYRP1 
intensity in a predefined area around the nucleus of every cell. Because TYRP1 is 
specifically sorted to melanosomes, spots are roughly equivalent to melanosomes in this 
model. The algorithm returns several output values after image analysis, such as the 
number or size of spots per cell, or the signal intensity per spot or per cell.  
Melan-a cells grown in a 96-well plate were transfected with the constructs giving the 
strongest effects in the confocal experiment (v2LMM_12467 against TYRP1, 
v2LMM_76067 against dysbindin, v2LMM196168 and v2LMM_224489 against HPS5, 
v2LMM_7485 against Myosin Va, and v2LMM_37945 against UBPY) or with a non-
silencing control. The plate was fixed and stained after 72 hours and analyzed on 
Cellomics KSR with the Spot Detector BioApplication. Because the phenotype observed 
in confocal analysis was a reduction in TYRP1 levels, the Spot Detector BioApplication 
output value SpotTotalIntenPerObjectCh2 (reporting the total intensity of the Cy3-
labeled TYRP1 per cell) was expected to most closely resemble results obtained on 
confocal analysis.  
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The Spot Detector BioApplication was run twice: once reporting output values for 
TYRP1-labeled spots in transfected cells and the second time carrying out the same 
measurements on untransfected cells. Transfected cells were detected on the Cellomics 
KSR in the FITC channel. The pGIPZ vector expressed TurboGFP, which is itself 
fluorescent, but bleaches upon fixing cells with PFA. The TurboGFP signal was 
enhanced by labeling cells with an antibody against TurboGFP and a secondary FITC-
labeled antibody. To emulate the comparison of transfected and untransfected cells per 
well, which was expressed using P-values in confocal analysis, the 
SpotTotalIntenPerObjectCh2 output value for transfected cells was normalized over the 
value obtained from untransfected cells in the same well. For wells where the TYRP1 
intensity is very similar between transfected and untransfected cells, this value 
approaches 1. For wells where the difference between transfected and untransfected cells 
is large (corresponding to a low P-value in the confocal experiment) the normalized 
TYRP1 intensity on Cellomics analysis is low. Other output values, such as the number 
or size of the spots, were calculated by Cellomics KSR but showed no difference between 
any of the samples and the negative controls, so only the TYRP1 intensity is reported 
here. 
Figure 4 shows the normalized result of a Cellomics scan for the top hits of the confocal 
analysis, reported in grid fashion corresponding to the order of the samples on the plate. 
To better visualize the data, colours were assigned to normalized levels on the red-green 
scale, where red represents the lowest normalized values and green the values closest to 
1. It is obvious from this figure that only knockdown of TYRP1 itself reduced TYRP1 
enough to be detected by Cellomics KSR with Spot Detector BioApplication. In this 
figure, all six transfections with pGIPZ against TYRP1 correspond to the six wells with 
the lowest TYRP1 levels in transfected cells. In a repeat experiment, five out of six 
TYRP1 knockdown transfections had the lowest reported TYRP1 values of the plate (not 
shown). None of the other transfections are detected as hits in this analysis. 
V2LMM_224489, the knockdown construct against HPS5 that was a reproducible hit in 
the confocal microscopy experiment does not appear to show any further TYRP1 
reduction than non-silencing controls. 
Validation of Knockdown 
The above results indicate that, other than TYRP1 itself, none of the knockdown 
constructs reduce TYRP1 levels enough to be detectable by Cellomics KSR analysis. 
Nevertheless, these target genes were selected based on their predicted effects on 
melanosome properties or other aspects of pigmentation. According to the literature, 
reduction of TYRP1 levels was expected for knockdown of BLOC-1 or BLOC-2 
components (pallidin, dysbindin, cappuccino, HPS5) and altered distribution of 
melanosomes was expected upon knockdown of Myosin Va or melanophilin.  
To investigate what caused the absense of expected phenotypic changes, knockdown 
levels were determined using quantitative real time PCR (RT-PCR) on cDNA prepared 
from FACS sorted cells transfected with pGIPZ constructs. The residual mRNA levels in 
every RT-PCR experiment were normalized to mRNA levels for the protein of interest in 
cells transfected with a non-silencing control plasmid. Figure 5 shows the results of these 
experiments. Every sample was measured at least in triplicate (most samples in 
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quadruplicate) and some experiments were repeated in their entirety to confirm that the 
RT-PCR results were indeed reproducible.  
The results indicate that of the investigated proteins, TYRP1 is most effectively knocked 
down by its corresponding shRNA construct, reducing mRNA levels to approximately 5-
15% of the levels in non-silencing control (results from two separate experiments each 
measured in quadruplicate). Since TYRP1 was used as melanosomal label in all confocal 
and microscopy experiments, the approximate reduction in protein level for this 
knockdown construct could be determined: Cellomics analysis of spot intensity shows 
that TYRP1 protein levels were reduced to ~50-60% compared to both TYRP1 levels in 
untransfected cells in the same well, and to TYRP1 levels in cells transfected with a non-
silencing control in the same plate.  
While TYRP1 mRNA levels were reduced by about 90%, knockdown of other proteins, 
such as mahogunin or LYST, was minimal, even at the mRNA level. This may explain 
why cells transfected with these knockdown constructs did not differ from negative 
controls. Other constructs, such as those targeting cappuccino, show a reduction of about 
50% at the mRNA level, but no effect on TYRP1 levels in confocal analysis.  
Melanophilin Knockdown 
Many of the proteins targeted in these experiments had been studied previously by others, 
using cells from mutant mice or from human patients with pigmentation disorders, but 
not using knockdown in cultured melanocytes. Only knockdown of melanophilin in 
melan-a cells was previously reported 
21
. Kuroda and Fukuda showed an expected 
perinuclear distribution in cells in which melanophilin levels were reduced, but we did 
not observe a similar distribution pattern in cells transfected with any of the three pGIPZ 
constructs against melanophilin. RT-PCR results show that none of these constructs 
strongly reduce melanophilin levels. Only v2LMM_73840 reduces mRNA levels by 
about 50%.  
In these studies, knockdown efficiency was determined by RT-PCR rather than a direct 
measurement of protein levels for several reasons: melan-a cells did not yield enough 
cells after FACS sorting to carry out western blot analysis, FACS-sorted cells did not 
survive reseeding to increase cell number, and for many of the proteins investigated no 
antibodies were available. There is, however, a commercially available antibody against 
melanophilin. Using this antibody, residual protein levels were measured upon 
melanophilin knockdown using confocal analysis and Volocity software, as was done for 
TYRP1 levels. After Volocity analysis of melanophilin levels, it became clear that even 
though there is a slight reduction of melanophilin at the mRNA level, the protein levels 
are not markedly reduced (Figure 6). However, there is a large variation in melanophilin 
levels between individual cells, as shown by the distribution of intensities in Figure 6. 
Figure 7 shows the confocal images of a cell with very little melanophilin levels. The 
bright field image of this particular cell does appear to show a perinuclear localization of 
melanosomes, and in a repeat experiment, a few other cells with very low melanophilin 
levels also showed perinuclear localization. This highlights the variation in phenotype 
within a sample, and furthermore suggests that protein levels need to be very low to 
detect any effect of melanophilin reduction.   
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Discussion 
Eleven genes that are either known to be directly involved in melanosome development 
or transport, or likely to affect pigmentation or organelle formation, were knocked down 
in melan-a cells using pGIPZ shRNAmir constructs from the Hannon-Elledge shRNAmir 
library. Of the eleven proteins knocked down in these experiments, only TYRP1 
knockdown (using v2LMM_12467) caused phenotypic changes that were repeatedly 
detected by both confocal and Cellomics analysis (Figures 2 and 4). Not only is TYRP1 
the protein that showed the largest decrease in mRNA levels upon knockdown (Figure 5), 
but its knockdown is also the direct output value measured in these systems. Knockdown 
of all other proteins is measured indirectly in terms of their effect on TYRP1 levels. The 
Cellomics KSR was not able to accurately detect the indirect effect of HPS5 knockdown 
by v2LMM_224489 on TYRP1 levels, even though this is detected in confocal analysis 
(Figures 2 and 4). The observed reduction of TYRP1 levels in response to HPS5 
knockdown by v2LMM_224489 is, however, in line with observations by others: In 
melanocytes of HPS5 patients, TYRP1 levels are significantly reduced 
17
.  
HPS5 is a component of the BLOC-2 complex, which is involved in the sorting of 
TYRP1 to melanosomes 
18
. Based on this, an effect of knockdown of dysbindin, pallidin, 
and cappuccino was also expected. These proteins are components of the BLOC-1 
complex, which is also required for TYRP1 sorting and acts upstream of BLOC-2. Mice 
lacking any of the BLOC-1 proteins are hypopigmented - almost white 
13
. However, none 
of the knockdown constructs against these proteins caused a reproducible effect on 
TYRP1 levels (Figures 2 - 4 and table 4). RT-PCR showed negligible knockdown of 
dysbindin (Figure 5). Cappuccino and pallidin knockdown constructs reduce mRNA 
levels to about 50-70% of control levels, but this appears to have no effect on TYRP1 
levels, even though a relation between pallidin and TYRP1 levels has been shown by 
others 
14
. However, in work by Setty et al., mice with mutant inactive pallidin were 
studied, and in our experiments at least 50% of residual pallidin is still present (possibly 
more at the protein level).  
It should be noted that Hermansky-Pudlak Syndrome and Griscelli Syndrome are both 
recessive disorders 
5-8
. Carriers, with only one mutated gene (heterozygotes), do not show 
the disease phenotype. This supports out observation that an approximate 50% reduction 
in mRNA levels does not lead to a phenotypic change. In light of this, it appears that 
many of the genes investigated here are not sufficiently knocked down to cause 
downstream effects. The Hannon-Elledge library reportedly achieved 60% reduction of 
RNA levels or more for about 80% of the constructs in a test set 
31
. In this work, a similar 
reduction is observed in only 6 of 23 tested constructs (Figure 5). It is possible that 
knockdown is cell-line specific, or that this particular set of shRNAmir constructs shows 
below average knockdown efficiency.  
In addition, depending on the half-life of the protein, a reduction in mRNA levels may 
have little effect on protein levels. This is illustrated by the observed knockdown of 
melanophilin: even though v2LMM_73840 appeared to reduce melanophilin levels to 
approximately 50% of control, no overall reduction was detected at the protein level 
(Figures 5C and 6). Only in cells with extremely low melanophilin protein levels 
(intensity ~20% of the mean melanophilin intensity) was perinuclear localization visible 
(Figure 7). A recent study also showed that Myosin Va, which is part of the same 
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transport complex, requires prolonged knockdown in order to see an effect on 
melanosome location 
32
. 
In conclusion, investigation of knockdown of a small set of proteins suggests that 
transient transfection of pGIPZ RNAi constructs is not sufficient to identify proteins 
involved in melanosome formation or transport using high-content RNAi screening: 
Many constructs show only limited knockdown at the mRNA level, residual protein 
(even after mRNA removal) may still elicit an effect, and the melanosomal system 
appears to be particularly robust to changes in protein levels, requiring near depletion of 
proteins to elicit an effect. These problems can potentially be overcome in part by 
lentiviral infection of the knockdown construct, which allows the pGIPZ hairpin to 
integrate into the genome and reduce protein levels over a longer period of time.  
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Table 1 
 
Table 1: Proteins selected for knockdown in experiments searching for a positive control 
for Cellomics KSR analysis. These targets have been linked to melanin synthesis 
(TYRP1, Mahogunin), development of melanosomes or other lysosome-related 
organelles (cappuccino, pallidin, dysbindin, HPS5, LYST, UBPY), transport of 
melanosomes (Myosin Va, melanophilin) or dendrite extension (RhoA). (see text for 
references) 
Protein  Function 
TYRP1 Required for synthesis of eumelanin. Sorted to late stage melanosomes.  
Cappuccino Component of BLOC-1  
Pallidin Component of BLOC-1. Mice with a mutation in pallidin have almost no 
mature melanosomes, and TYRP1 sorting is impaired  
Dysbindin Component of BLOC-1. Mice with a mutation in dysbindin have almost no 
mature melanosomes. In humans, dysbindin mutations are associated with 
Hermansky-Pudlak Syndrome type 7 and with schizophrenia  
HPS5 Component of BLOC-2. Mutated in Hermansky-Pudlak Syndrome type 5 
patients, and reduces number of mature melanosomes and TYRP1 levels in 
these patients  
LYST Mutated in Chediak-Higashi Syndrome. Mutation leads to formation of giant 
lysosomes and melanosomes.  
Myosin Va Mutated in Griscelli Syndrome Type 1. Necessary for transport of 
melanosomes.  
Melanophilin Mutated in Griscelli Syndrome Type 3. Necessary for transport of 
melanosomes. Knockdown in melan-a cells causes perinuclear localization of 
melanosomes.  
UBPY (USP8) Deubiquitinating enzyme, necessary for proper sorting to endosomes. 
Knockdown in HeLa cells affects shape of endosomes and MVBs. Mouse 
mutant is embryonic lethal.  
Mahogunin an E3 ubiquitin ligase required  for  endosome to lysosome trafficking  and 
for pigment type switching between eumelanin and pheomelanin.  
RhoA Chemical inhibition in B16 cells induces dendrite outgrowth 
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Table 2 
 
Gene name GenBank ID (mouse) 
Open Biosystems 
Construct ID 
TYRP1 NM_031202 v2LMM_12467 
Cappuccino NM_133724 v2LMM_21767 
  v2LMM_250967 
Pallidin NM_019788 v2LMM_24372 
  v2LMM_28461 
  v2LMM_36292 
Dysbindin NM_025772 v2LMM_76067 
HPS5 NM_001005248 v2LMM_196168 
  v2LMM_92618 
  v2LMM_224489 
LYST NM_010748  v2LMM_4222 
  v2LMM_11529 
  v2LMM_10733 
Myosin Va NM_010864 v2LMM_4868 
  v2LMM_7485 
  v2LMM_17673 
Melanophilin AF384098 v2LMM_73840 
  v2LMM_70729 
  v2LMM_62443 
UBPY NM_019729 v2LMM_37945 
Mahogunin NM_029657 v2LMM_66590 
  v2LMM_75408 
RhoA NM_016802 v2LMM_50451 
Non-silencing control RHS4346* 
 
Table 2: pGIPZ constructs transcribing hairpins from the Hannon-Ellegde shRNAmir 
library were obtained from OpenBiosystems. Every available shRNAmir hairpin against 
each gene is listed. GenBank IDs refer to the mouse genome.  
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Table 3 
 
 RT-PCR primer pairs 
Gene Forward primer Reverse primer 
PCR 
product 
size (bp) 
TYRP1 ACACTTTGTAACAGCACTGAG ATCATTGGGAGACAAATGGGT 290 
Dysbindin GAAGCCTTCAAAGCTGAACTC ACATCACAATGTTGTCCTCTC 300 
Pallidin CTGCTGTCCCACTACTTACC CATCTCCTTCCTTATAGTCACCAG 200 
Cappuccino CAGGATGGAGGAGCAGGTC CTCGGTCCGAAACAGGACT 163 
HPS5  ACACCAGTTCAAGAAGCTCC GCTACATCCTGAATATCCTTGAC 230 
Melanophilin ATGTAGCCCTTTACCCTCTG CTCCAAGATCTGAGTCTCAGG 243 
Myosin Va GGAGAGGAAGTTAGTAGAAGAG TTAGGCACATTCAGCATCAG 152 
LYST CCATCATAAGCCTGACATTCTC GACACTCCTTCTCTTCATCC 162 
RhoA CTTCAATCCAGAAGAAACTGGTG GCGGTCATAATCTTCTTGTCC 204 
UBPY TATTTCAACCGAAACTGCTACC CCGATTGTCAGCCTTATTCAG 260 
Mahogunin ATGATGAGCTGAACTTTGACC TTGTTCTTGTTCTCGATGCC 228 
Actin GATGACCCAGATCATGTTTGAG CTTCTCTTTGATGTCACGCAC 291 
 
Table 3: Primers used for RT-PCR. To avoid amplifying residual genomic DNA all 
primers were designed (with PerlPrimer) to cross intron-exon boundaries with the 
exception of those against the single-exon gene Cappuccino 
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Table 4 
 
  Knockdown Retested 
pGIPZ ID gene 48 hr 72 hr 72hr 
v2LMM_12467 TYRP1 ** ** *** 
v2LMM_76067 Dysbindin * ***  
v2LMM_196168 HPS5 * *  
     
v2LMM_224489 HPS5  *** *** 
v2LMM_7485 Myosin Va  ***  
     
v2LMM_37945 UBPY  **  
     
v2LMM_75408 Mahogunin  *  
v2LMM_36292 Pallidin  *  
v2LMM_50451 RhoA  *  
v2LMM_73840 Melanophilin  *  
     
v2LMM_4222 LYST *   
v2LMM_4868 Myosin Va *   
v2LMM_21767 Cappuccino *   
v2LMM_17673 Myosin Va *   
     
v2LMM_24372 Pallidin    
v2LMM_28461 Pallidin    
v2LMM_92618 HPS5    
v2LMM_70729 Melanophilin    
v2LMM_11529 LYST    
v2LMM_10733 LYST    
v2LMM_62443 Melanophilin    
v2LMM_66590 Mahogunin    
v2LMM_250967 Cappuccino    
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Table 4: Results from confocal experiments 
To quantify results from the confocal experiments (see Figures 2 and 3), TYRP1 levels 
were measured using Volocity software for both transfected and untransfected cells in 
each sample, and a ranking order was based on P-values for unpaired T-test between 
measurements from transfected and untransfected cells. Samples that showed a 
statistically significant (P<0.05) difference between transfected and untransfected cells at 
both 48 hour and 72 hour knockdown were ranked highest, followed by those which only 
showed a significant difference at 72 hour knockdown, followed by samples only 
significant at 48 hour knockdown or not at all. 
At both time points (48 and 72 hour knockdown), two out of eight negative controls 
samples (transfected with non-silencing pGIPZ plasmid) showed a difference in TYRP1 
levels between transfected and untransfected cells with P<0.05 (see Figures 2 and 3). 
Therefore, any samples that only showed up once with P<0.05 were considered no more 
significant than negative controls. This is indicated by a horizontal line in table 4. 
The top samples (above the horizontal line) were retested at 72 hour knockdown, and 
only v2LMM_12467 and v2LMM_224489 showed a reproducible effect on TYRP1 
levels.  
Data were collected in blinded experiments and later annotated with the corresponding 
pGIPZ ID numbers. 
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Figure 1 
 
 
 
Figure 1: Reduction of TYRP1 levels 
After 72 hour transfection, some cells transfected with the pGIPZ constructs 
v2LMM_12467 (against TYRP1, top) or v2LMM_224489 (against HPS5, bottom) 
showed a decrease in TYRP1 levels (arrows in second column).  
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Figure 2 
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Figure 2:  Quantified TYRP1 levels per cell after 48 hour transfection with pGIPZ 
constructs.  
For each sample of melan-a cells grown in 4-well chamber slides, TYRP1 levels per cell 
were determined using Volocity software for both transfected and untransfected cells, to 
account for variations in TYRP1 intensity between wells or slides. The differences 
between values for transfected and untransfected cells per sample were evaluated using 
an unpaired T-test, and asterisks indicate statistical significance: *=P<0.05, **=P<0.01, 
***=P<0.001. P-values for these samples are ranked in Table 4. Data were collected in a 
blinded experiment and later annotated with the correct pGIPZ ID. Error bars indicate 
standard error of the mean. 
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Figure 3 
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Figure 3: Quantified TYRP1 levels per cell after 72 hour transfection with pGIPZ 
constructs. 
For each sample of melan-a cells grown in 4-well chamber slides, TYRP1 levels per cell 
were determined using Volocity software for both transfected and untransfected cells, to 
account for variations in TYRP1 intensity between wells or slides. The differences 
between values for transfected and untransfected cells per sample were evaluated using 
an unpaired T-test, and asterisks indicate statistical significance: *=P<0.05, **=P<0.01, 
***=P<0.001. P-values for these samples are ranked in Table 4. Data were collected in a 
blinded experiment and later annotated with the correct pGIPZ ID. Error bars indicate 
standard error of the mean. 
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Figure 4 
 
 
 
Figure 4: Cellomics analysis 
The knockdown constructs that led to the highest reduction in TYRP1 levels in melan-a 
cells on confocal analysis were tested using Cellomics KSR high content analysis. Here 
TYRP1 levels were measured as the output value SpotTotalIntenPerObjectCh2 of the 
Spot Detector BioApplication. To correct for variations between wells, the output for 
transfected cells in every well was normalized to that for untransfected cells in the same 
well. In this figure, this normalized value is indicated per well by a colour as shown in 
the legend. Samples are shown in their respective location in a 96-well plate. Only 
v2LMM_12467 shows a detectable reduction in TYRP1 levels compared to non-silencing 
controls in Cellomics analysis. See Appendix 2 for data. N
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Figure 5 
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Figure 5: RT-PCR results 
RT-PCR results showing residual mRNA levels after knockdown with pGIPZ shRNAmir 
constructs vs. non-silencing control. All samples were FACS-sorted before RNA 
isolation, so only cells containing the TurboGFP-expressing pGIPZ vector were analyzed. 
Error bars indicate standard deviation. A. Knockdown efficiency of constructs that 
showed a reproducible effect on TYRP1 levels in confocal analysis. B. Knockdown 
efficiency of constructs that showed a variable effect on TYRP1 levels in confocal 
analysis. C. Knockdown efficiency of constructs that showed no effect on TYRP1 levels 
in confocal analysis. 
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Figure 6 
 
 
Figure 6: Melanophilin protein levels 
Melanophilin levels per cell, quantified using Volocity software from confocal images of 
cells labeled with an antibody against Melanophilin and secondary Cy3-labeled F(ab')2  
antibody fragment. Cells were transfected with pGIPZ constructs transcribing shRNAmir 
hairpins against melanophilin, or with a non-silencing control. Untransfected cells in each 
well were measured to account for variation in signal intensities between wells. 
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Figure 7 
 
 
 
Figure 7: Melanosome transport is inhibited at very low melanophilin levels 
In a cell where melanophilin levels are extremely low (last panel, arrow) upon 72 hour 
knockdown with v2LMM_73840, melanosomes are localized near the nucleus instead of 
spreading throughout the cell (middle panel). 
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Appendix 1 
Selection parameters and assay setting for Spot Detector BioApplication 
 
These settings of the Spot Detector BioApplication (V2; version 4.1.0.2029) are used to 
identify melanosomes on Cellomics KSR. 
 
1.1 Selection parameters 
Channel 1: Nucleus (Focus channel) 
Object Identification 
Method IsodataThreshold  
Value -0.5  
Object Selection Parameter Min Max 
ObjectArea 1 500 
ObjectShapeBFR 0 1 
ObjectShapeBAR 0 10 
ObjectAvgInten 0 4095 
ObjectTotalInten 0 10000000000 
 
 
Channel 2: Target 
Object Identification 
Method FixedThreshold  
Value 25  
Object Selection Parameter Min Max 
SpotAreaCh2 0 250000 
SpotShapeBFRCh2 0 1 
SpotShapeBARCh2 0 10 
SpotAvgIntenCh2 25 4095 
SpotTotalIntenCh2 0 10000000000 
TargetAvgIntenCh2 0 4095 
TargetTotalIntenCh2 0 10000000000 
 
 
  
Channel 3: GFP   
Object Identification   
Method None  
Value 1243  
Object Selection Parameter Min Max 
SpotAreaCh3 0 33 
SpotShapeBFRCh3 0 1 
SpotShapeBARCh3 0 1.143 
SpotAvgIntenCh3 0 810.485 
SpotTotalIntenCh3 0 25746 
TargetAvgIntenCh3 25* 4095* 
TargetTotalIntenCh3 0 1068080 
* These values are for the selection of transfected cells. For the selection of untransfected 
cells TargetAvgIntenCh3 min=0 and max=24.999 
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1.2 Assay Settings 
Assay Parameters Value 
PixelSize 1.36 
MinRefObjectCountPerField 2 
SmoothMethodCh1 1 
SmoothMethodCh2 1 
SmoothMethodCh3 1 
SpotCountPerObjectLevelHighCh2 32766 
SpotCountPerObjectLevelHighCh2_CC 1 
SpotCountPerObjectLevelHighCh3 32766 
SpotCountPerObjectLevelHighCh3_CC 1 
SpotCountPerObjectLevelLowCh2 0 
SpotCountPerObjectLevelLowCh2_CC 1 
SpotCountPerObjectLevelLowCh3 0 
SpotCountPerObjectLevelLowCh3_CC 1 
SpotDetectMethodCh1 1 
SpotDetectMethodCh2 2 
SpotDetectMethodCh3 1 
SpotTotalAreaPerObjectLevelHighCh2 1048576 
SpotTotalAreaPerObjectLevelHighCh2_CC 1 
SpotTotalAreaPerObjectLevelHighCh3 1048576 
SpotTotalAreaPerObjectLevelHighCh3_CC 1 
SpotTotalAreaPerObjectLevelLowCh2 0 
SpotTotalAreaPerObjectLevelLowCh2_CC 1 
SpotTotalAreaPerObjectLevelLowCh3 0 
SpotTotalAreaPerObjectLevelLowCh3_CC 1 
SpotTotalIntenPerObjectLevelHighCh2 10000000000 
SpotTotalIntenPerObjectLevelHighCh2_CC 1 
SpotTotalIntenPerObjectLevelHighCh3 10000000000 
SpotTotalIntenPerObjectLevelHighCh3_CC 1 
SpotTotalIntenPerObjectLevelLowCh2 0 
SpotTotalIntenPerObjectLevelLowCh2_CC 1 
SpotTotalIntenPerObjectLevelLowCh3 0 
SpotTotalIntenPerObjectLevelLowCh3_CC 1 
UseMicrometers 0 
BackgroundCorrection 50 
ObjectSegmentationCh1 5 
ResponderDisplayModeCh2 2 
ResponderDisplayModeCh3 2 
SmoothFactorCh1 1 
SmoothFactorCh2 0 
SmoothFactorCh3 0 
SpotDetectRadiusCh1 0 
SpotDetectRadiusCh2 3 
SpotDetectRadiusCh3 0 
TargetCircModifierCh2 5 
TargetCircModifierCh3 0 
TargetRingDistanceCh2 0 
TargetRingDistanceCh3 0 
TargetRingWidthCh2 0 
TargetRingWidthCh3 0 
UseGatingCh2 1 
UseGatingCh3 1 
UseReferenceWells 0 
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Appendix 2  
Data from Cellomics analysis used to create Figure 4 
Location of samples on plate: 
 1 2 3 4 5 6 7 8 9 10 11 12 
A                         
B   ns 12467 12467 12467 ns 224489 224489 224489 ns ns   
C   ns 76067 76067 76067 ns 7485 7485 7485 ns ns   
D   ns 196168 196168 196168 ns 37945 37945 37945 ns ns   
E   ns 224489 224489 224489 ns 12467 12467 12467 ns ns   
F   ns 7485 7485 7485 ns 76067 76067 76067 ns ns   
G   ns 37945 37945 37945 ns 196168 196168 196168 ns ns   
H                         
             
 
SpotTotalIntenPerObjectCh2 values for transfected cells (gated by GFP channel: 
TargetAvgIntenCh3 > 25) 
 1 2 3 4 5 6 7 8 9 10 11 12 
A                         
B   5514.34 3269.08 1900.75 2023.9 3750.3 4579.55 3047.49 2482.83 2946.95 3051.86   
C   4230.45 4252.93 3269.52 3393.15 6908.83 3292.14 7158.78 3347.76 3143.86 2481.87   
D   5368.22 4469.16 7670.35 2957.78 3184.9 2617.88 2062.32 2586.93 2777.26 2332.25   
E   5420.45 3683.38 3211.61 3604.5 4199.65 1953.88 1549.1 1877.64 4646.09 2289.85   
F   4219.2 4303.37 6083.06 3314.59 3199.96 2523.36 2012.44 2416.49 2515.43 1856.39   
G   4799.22 3544.43 2530.83 6961.27 3405.41 3240.78 2178.9 2591.48 2599.84 2473.61   
H                         
 
SpotTotalIntenPerObjectCh2 values for untransfected cells (gated by GFP channel: 
TargetAvgIntenCh3 < 24.999) 
 1 2 3 4 5 6 7 8 9 10 11 12 
A                         
B   6147.85 5609.09 3870.02 3917.5 4108.33 3111.6 3519.42 2976.54 2892.34 2955.67   
C   6072.38 4639.74 3950.07 4321.65 3997.96 3334.06 2990.84 3006.04 3084.32 2553.95   
D   6545.25 5148.37 4183.15 3873.26 4099.35 3499.58 2598.61 3144.81 3100.21 2691.33   
E   5906.55 5156.12 3978.77 4365.27 3876.45 3366.59 2804.89 3136.73 3068.6 2380.65   
F   5225.82 4558.9 3879.19 3680.21 4145.91 2754.09 3310.67 3152.14 3071.32 1980.98   
G   5860.61 4161.1 3703.07 3122.24 4310.23 3443.5 2931.22 3488.14 3109.96 1497.74   
H                         
 
Normalized value = [SpotTotalIntenPerObjectCh2]trf/[ SpotTotalIntenPerObjectCh2]untrf 
 1 2 3 4 5 6 7 8 9 10 11 12 
A                         
B   0.8970 0.5828 0.4911 0.5166 0.9129 1.4718 0.8659 0.8341 1.0189 1.0325   
C   0.6967 0.9166 0.8277 0.7852 1.7281 0.9874 2.3936 1.1137 1.0193 0.9718   
D   0.8202 0.8681 1.8336 0.7636 0.7769 0.7481 0.7936 0.8226 0.8958 0.8666   
E   0.9177 0.7144 0.8072 0.8257 1.0834 0.5804 0.5523 0.5986 1.5141 0.9619   
F   0.8074 0.9439 1.5681 0.9007 0.7718 0.9162 0.6079 0.7666 0.8190 0.9371   
G   0.8189 0.8518 0.6834 2.2296 0.7901 0.9411 0.7433 0.7429 0.8360 1.6516   
H                         
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